Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/07 02:11:45 pm
132.185 USD   -0.22%
12/03Health Care Ticks Lower As Pfizer Gains - Health Care Roundup
DJ
11/29Thermo Fisher says its COVID-19 tests accurately detects Omicron variant
RE
11/18INSIDER SELL : Abbott Laboratories
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/01/2021 12/02/2021 12/03/2021 12/06/2021 12/07/2021 Date
126.74(c) 128.38(c) 130.27(c) 132.47(c) 132.21 Last
4 816 874 5 090 982 5 254 610 6 601 840 2 655 209 Volume
+0.77% +1.29% +1.47% +1.69% -0.20% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 42 050 M - -
Net income 2021 6 560 M - -
Net Debt 2021 8 142 M - -
P/E ratio 2021 35,8x
Yield 2021 1,28%
Sales 2022 39 983 M - -
Net income 2022 6 544 M - -
Net Debt 2022 3 661 M - -
P/E ratio 2022 36,7x
Yield 2022 1,33%
Capitalization 234 B 234 B -
EV / Sales 2021 5,76x
EV / Sales 2022 5,95x
Nbr of Employees 109 000
Free-Float 88,5%
More Financials
Company
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products,... 
More about the company
Ratings of Abbott Laboratories
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about ABBOTT LABORATORIES
12/03Health Care Ticks Lower As Pfizer Gains - Health Care Roundup
DJ
11/29Thermo Fisher says its COVID-19 tests accurately detects Omicron variant
RE
11/18INSIDER SELL : Abbott Laboratories
MT
11/17Abbott launches similac 360 total care with exclusive blend of five hmo prebiotics and ..
AQ
11/16Abbott Laboratories Launches Similac 360 Total Care Infant Formula
MT
11/16Abbott Launches Similac® 360 Total Care® with Exclusive Blend of Five HMO Prebiotics an..
PR
11/16Abbott Launches Similac? 360 Total Care? with Exclusive Blend of Five Hmo Prebiotics an..
CI
11/16Talis Biomedical Names Brian Blaser Chief Executive
MT
11/15Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow..
PR
11/15Abbott's new leadless pacemaker system meets primary endpoints in pivotal trial
AQ
11/12Abbott Laboratories Says its New Leadless Pacemaker Meets Safety, Efficacy Endpoints
MT
11/12Abbott Laboratories New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Tr..
CI
11/09Abbott and the American Diabetes Association? Launch First-of-Its-Kind Community Initia..
CI
11/04Abbott launches new initiative to drive diversity in medical research and improve care ..
AQ
11/03ABBOTT LABORATORIES Management's Discussion and Analysis of Financial Condition and Re..
AQ
More news
News in other languages on ABBOTT LABORATORIES
03:44aAVIS D'ANALYSTES DU JOUR : Pirelli, Galapagos, Siemens, Astrazeneca, Covestro, Abbott, Soi..
03:19aEl club de los optimistas incorregibles
03:07aLe club des incorrigibles optimistes
02:22aEN DIRECT DES MARCHES : Safran, Engie, Stellantis, Veolia, Worldline, Intel, Volkswagen, S..
02:16aAVIS D'ANALYSTES DU JOUR : Air Liquide, Dassault Systèmes, Schneider, Arkema, Soitec, Gala..
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Stock Trading Strategies
ABBOTT LABORATORIES - 01/20
Close to a key resistance level
BUY
More Stock Trading Analysis
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 132,47 $
Average target price 135,94 $
Spread / Average Target 2,62%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES20.99%234 245
MEDTRONIC PLC-5.89%148 224
BECTON, DICKINSON AND COMPANY-2.44%69 910
HOYA CORPORATION25.75%58 349
DEXCOM, INC.41.85%50 829
ALIGN TECHNOLOGY, INC.19.56%50 381